A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ravi Salgia, MD
City of Hope Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Pan American Center for Oncology Trials (panoncology Trials)
Rio Piedras, Puerto Rico, Puerto Rico
- City of Hope
Duarte, California, United States
- California Cancer Associates for Research and Excellence, Inc. (ccare)
Encinitas, California, United States
- Providence Medical Foundation
Fullerton, California, United States
- California Cancer Associates for Research and Excellence, Inc. (ccare)
San Marcos, California, United States
- Sarcoma Oncology
Santa Monica, California, United States
- Ucla Hematology/oncology
Santa Monica, California, United States
- Orlando Health, Inc.
Orlando, Florida, United States
- Brcr Medical Center
Plantation, Florida, United States
- Gabrail Cancer Center
Canton, Ohio, United States
- Texas Oncology - Tyler
Tyler, Texas, United States
- Virginia Cancer Specialists
Fairfax, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Dec 2021
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2026
- Last update posted
- 24 Sept 2025
- Registered enrollment
- 42
- Registry id
- NCT05163028
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.